Fundraising Fox

Astute Medical

San Diego, US · Delaware corporation · 2 known investors

bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.

BiotechHealthtechMedical Devices

Founders & leadership

TM
Todd MyersExecutive
CH
Christopher HibberdNamed on SEC filing
KB
Kenneth BuechlerNamed on SEC filing
PM
Paul McPhersonNamed on SEC filing

Board

JB
James BlairBoard director
JS
James ScopaBoard director
DD
David DouglassBoard director
FD
Frederick DotzlerBoard director
KB
Kim BlickenstaffBoard director

Investors · 2

Kaiser Permanente VenturesSan Francisco · $2M – $5M
Moore Venture PartnersSan Diego

Reported raises · per SEC filings

Form D private placements

$91.1M disclosed across 5 rounds · 2014–2016

▶$43MraisedDec 2016 · 18 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd MyersExecutive Officer
  • David DouglassDirector
  • James BlairDirector
  • Christopher HibberdExecutive Officer, Director
  • Kenneth BuechlerDirector
  • James ScopaDirector
  • Kim BlickenstaffDirector
  • Frederick DotzlerDirector
  • Paul McPhersonExecutive Officer, Director
Offering amount
$43M
Amount sold
$43M
Sales commissions
$2M
Placement agents
PIPER JAFFRAY & CO.
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2016 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Kim BlickenstaffDirector
  • Kenneth BuechlerDirector
  • Todd MyersExecutive Officer
  • James BlairDirector
  • Frederick DotzlerDirector
  • David DouglassDirector
  • Christopher HibberdExecutive Officer, Director
  • Paul McPhersonExecutive Officer, Director
  • James ScopaDirector
Amount sold
$3M
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedOct 2015 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • James BlairDirector
  • Todd MyersExecutive Officer
  • James ScopaDirector
  • Kim BlickenstaffDirector
  • Christopher HibberdExecutive Officer, Director
  • Kenneth BuechlerDirector
  • David DouglassDirector
  • Paul McPhersonExecutive Officer, Director
  • Frederick DotzlerDirector
Offering amount
$28M
Amount sold
$20M
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.1MraisedJul 2014 · 35 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd MyersExecutive Officer
  • Christopher HibberdExecutive Officer, Director
  • Kenneth BuechlerDirector
  • Paul McPhersonExecutive Officer, Director
  • David DouglassDirector
  • Frederick DotzlerDirector
  • James ScopaDirector
  • James BlairDirector
  • Kim BlickenstaffDirector
Offering amount
$20.1M
Amount sold
$20.1M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMar 2014 · 31 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher HibberdExecutive Officer, Director
  • Todd MyersExecutive Officer
  • Kenneth BuechlerDirector
  • Kim BlickenstaffDirector
  • Frederick DotzlerDirector
  • James ScopaDirector
  • Paul McPhersonExecutive Officer, Director
  • James BlairDirector
  • David DouglassDirector
Amount sold
$5M
First sale
Jan 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Akute Health3 shared keywordsAkute Health is an electronic health record (EHR) system designed for independent, cash-based clinical practices including direct primary care, med spas, and telehealth clinics. The platform offers task-based workflows, patient communication tools, and administrative automation to reduce overhead and enable providers to focus on patient care.

Companies competing with Astute Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Astute Medical do?
bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.
Who are Astute Medical's investors?
Astute Medical's investors include Kaiser Permanente Ventures, Moore Venture Partners.
How much funding has Astute Medical raised?
Astute Medical has disclosed $91.1M raised across 5 rounds.
Where is Astute Medical headquartered?
Astute Medical is headquartered in San Diego, US.